In a surprising development, the U.S. Department of Justice filed a brief telling the U.S. Supreme Court that it wants to end a closely watched whistleblower lawsuit filed against Gilead Sciences (GILD) because it is “not in the public interest.”
Moreover, the Justice Department further indicated it would seek to dismiss the case if the Supreme Court were to send it back for further review by a federal circuit court, even though the agency appeared to support the legal theory underpinning the case.
About the Author Reprints
Question to our scribe – what if any action did FDA take against Gilead products in light of the contamination? None that i recall but “who am I?”